Pharmafile Logo
Pharmafocus logo
Advanced Search
pexels-matthias-zomer-339620

Study finds superior outcomes for fracture risk reduction in osteoporosis

April 26, 2021
Sales and Marketing

A real-world evidence study, presented at the International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders, has shown for the first …

News

Dermavant Sciences announce data of two Phase III trials for psoriasis

April 26, 2021
Sales and Marketing

Dermavant Sciences have presented successful data from two Phase III trials for tapinarof, for the treatment of psoriasis in adults, …

News
credit_-_daniel_leal-olivas-afp

LEO Pharma receives positive CHMP opinion for dermatitis treatment

April 26, 2021
Sales and Marketing CHMP, EMA, EU, dermatitis

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion …

News
sanofi_hq__boetie_hall_web

Sanofi’s RSV drug sees Phase III clinical trial success

April 26, 2021
Sales and Marketing AstraZeneca, Sanofi

Sanofi have announced positive topline results from the Phase III MELODY trial into nirsevimab, which demonstrated protection against respiratory syncytial …

News

Phoenix Cardiac gains CE Mark for “game-changer” MR device

April 26, 2021
Sales and Marketing CE Mark, EU, cardiovascular

Phoenix Cardiac Devices have received CE Mark certification for its BACE (basal annuloplasty of the cardia externally) device, a novel …

News
Top 10 news roundup

Phamafile.com’s top 10 news stories of the week

April 23, 2021
Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma, pharma news

Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine to have a significantly reduced …

News

Researchers find possible new treatment for several cancers

April 23, 2021
Medical Communications Cancer, The Institute of Cancer Research, cancer treatment, kidney cancer treatment, pharma, pharma news

Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …

News
lonza

Lonza to invest over £150 million on new molecule complex

April 23, 2021
Medical Communications Lonza

Lonza have announced the construction of a new small molecule manufacturing complex at its Visp site in Switzerland, which will …

News
img_4190-e1376666350337-web

MHRA gives green light to new cardiovascular treatment

April 23, 2021
Medical Communications MHRA, cardiovascular

The MHRA has granted a Great Britain Marketing Authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce the risk …

News
az

AstraZeneca drug evaluated in nine eosinophilic diseases

April 23, 2021
Medical Communications AstraZeneca

AstraZeneca announced on Thursday that the first patients had been dosed in the Phase III Fasenra (benralizumab) clinical trial in …

News
Lab testing

Lipidor to begin Phase III trial on psoriasis treatment

April 22, 2021
Phase III trials, lipidor, pharma, pharma news, psoriasis

Lipidor has submitted an application with the Indian Medical Products Agency to begin a Phase III trial on their drug …

News

Novo Nordisk to expand obesity study into oral treatment

April 22, 2021
Novo Nordisk, obesity

Novo Nordisk is planning to initiate a Phase IIIa study of oral semaglutide in obesity, expanding on its Phase IIIa …

News

Jubilant’s oral remdesivir formulation shows positive results in human trial

April 22, 2021
COVID-19, Gilead, Jubilant Pharma, covid-19 treatment, pharma, pharma news, remdesivir

Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an …

News

UK Company launches COVID-19 neutralisation assay development kit

April 22, 2021
COVID-19

The Native Antigen Company, a supplier of reagents for research into diagnostics and vaccines, have announced the launch of its …

News

Bharat Biotech jab shows 100% efficacy against severe COVID-19

April 22, 2021
COVID-19, India

Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen lots of COVID-19 developments; Avacta’s 20-minute COVID test has gained clinical validation, the EMA has …

News
Amgen flag

Amgen stomach cancer drug awarded Breakthrough Therapy Designation

April 21, 2021
Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news

Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …

News

J&J COVID-19 vaccine to resume Europe rollout

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, J&J, J&J vaccine, JJ, pharma, pharma news

The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.

News

GW Pharma’s cannabidiol gains EC approval

April 21, 2021
Research and Development EC, EU, cannabis

GW Pharmaceuticals has received European Commission (EC) approval for the type II variation application for Epidyolex (cannabidiol), as an adjunctive …

News

UK Government launches COVID-19 Antivirals Taskforce

April 21, 2021
Research and Development COVID-19, UK government

A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026